The Centre will be led by Robin Carhart-Harris, a leading UK figure in the new wave of psychedelic research. Carhart-Harris has worked for well over a decade in the field of psychopharmacology, and is known for completing the first modern brain imaging study of the effects of LSD.
“This new Centre represents a watershed moment for psychedelic science; symbolic of its now mainstream recognition,” says Carhart-Harris. “Psychedelics are set to have a major impact on neuroscience and psychiatry in the coming years. It’s such a privilege to be at the forefront of one of the most exciting areas in medical science. I am immensely grateful to the donors who have made all of this possible.”